<p>Clover Health Investments（纳斯达克：CLOV - 获取免费报告）可能会在 2026 年 5 月 6 日星期三市场收盘后公布其 2026 年第一季度的业绩。分析师预计该公司将公布每股收益为 0.07 美元，季度收入为 7.14894 亿美元。投资者可以访问该公司即将发布的 2026 年第一季度财报页面，以获取关于定于 2026 年 5 月 6 日下午 5:00（东部时间）的电话会议的最新信息。</p>
<ul>
<li>MarketBeat 周回顾 – 03/03 - 03/07</li>
</ul>
<p>Clover Health Investments（纳斯达克：CLOV - 获取免费报告）上一次发布财报是在 2 月 26 日星期四。该公司报告季度每股收益为（0.10）美元，低于分析师一致预期的（0.05）美元，差距为（0.05）美元。该公司季度收入为 4.8771 亿美元，而分析师预期为 4.6706 亿美元。Clover Health Investments 的股本回报率为负 25.17%，净利润率为负 4.45%。分析师平均预计 Clover Health Investments 在当前财年和下一个财年将发布每股收益为 0 美元。</p>
<h2>Clover Health Investments 股价上涨 4.8%</h2>
<p>Clover Health Investments 的股票在星期三开盘价为 2.64 美元。该公司的 50 日移动平均线为 2.02 美元，200 日移动平均线为 2.40 美元。该公司的市值为 13.9 亿美元，市盈率为-15.53，贝塔值为 2.24。Clover Health Investments 的 1 年最低价为 1.58 美元，1 年最高价为 3.92 美元。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>错过了 Hims &amp; Hers 的上涨？Clover Health 可能是下一个</li>
</ul>
<p>一些分析师最近对 CLOV 股票发表了看法。Leerink Partners 在 3 月 5 日星期四的报告中将 Clover Health Investments 的目标价从 3.00 美元下调至 2.50 美元，并对该公司给予了 “市场表现” 评级。Weiss Ratings 在 3 月 27 日星期五的报告中重申了对 Clover Health Investments 的 “卖出（d-）” 评级。Wall Street Zen 在 2 月 15 日星期日的报告中将 Clover Health Investments 的评级从 “卖出” 上调至 “持有”。最后，Canaccord Genuity Group 在 3 月 20 日星期五的报告中将 Clover Health Investments 的目标价从 3.70 美元下调至 3.20 美元，并对该公司给予了 “买入” 评级。一位研究分析师对该股票给予了买入评级，三位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，平均目标价为 2.90 美元。</p>
<p><strong>查看我们关于 Clover Health Investments 的最新股票报告</strong></p>
<h2>Clover Health Investments 的内部买卖情况</h2>
<p>在其他 Clover Health Investments 的新闻中，首席执行官 Brady Patrick Priest 在 3 月 4 日星期三出售了 175,000 股该公司的股票。股票以平均价格 2.17 美元出售，总交易额为 379,750.00 美元。交易完成后，首席执行官持有该公司 1,998,584 股股票，价值约为 4,336,927.28 美元。这笔交易代表了他们持股比例的 8.05% 的减少。该出售在向证券交易委员会提交的文件中披露，文件可通过此链接访问。公司内部人士持有该公司 24.07% 的股份。</p>
<h2>对 Clover Health Investments 的对冲基金观点</h2>
<p>机构投资者和对冲基金最近对该公司的持仓进行了调整。Sei Investments Co.在第二季度购买了 Clover Health Investments 的新头寸，价值约为 118,000 美元。Russell Investments Group Ltd.在第三季度购买了 Clover Health Investments 的新头寸，价值约为 104,000 美元。Virtu Financial LLC 在第三季度购买了 Clover Health Investments 的新头寸，价值约为 101,000 美元。加拿大养老金计划投资委员会在第二季度购买了 Clover Health Investments 的新头寸，价值约为 88,000 美元。最后，Mackenzie Financial Corp 在第三季度购买了 Clover Health Investments 的新头寸，价值约为 80,000 美元。机构投资者持有该公司 19.77% 的股份。</p>
<h2>关于 Clover Health Investments</h2>
<p>（获取免费报告）</p>
<p>Clover Health Investments 是一家以技术驱动的医疗保健公司，专注于为老年人群体提供医疗保险优势计划。该公司将保险覆盖与专有软件平台相结合，以改善护理协调、结果跟踪和成本管理。通过利用数据分析，Clover Health 旨在为其成员提供个性化的护理路径和预防干预措施。</p>
<p>Clover 的核心产品是其 Clover Assistant 平台，该平台从多个来源聚合临床和索赔数据，为医生和护理团队提供实时洞察。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，而不是 Clover Health Investments</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Clover Health Investments 吗？</h2>
<p>在你考虑 Clover Health Investments 之前，你需要听听这个。</p>
<p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每天推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 Clover Health Investments 并不在名单上。</p>
<p>虽然 Clover Health Investments 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

三叶草健康

<p>Clover Health Investments (NASDAQ:CLOV) 将于 5 月 6 日公布 2026 年第一季度财报，预计每股收益为 0.07 美元，收入为 7.1489 亿美元。该公司此前报告了 2025 年第四季度每股亏损 0.10 美元。分析师对该股票的评级不一，普遍评级为 “持有”，平均目标价为 2.90 美元。首席执行官 Brady Priest 最近出售了 175,000 股，减少了 8.05% 的持股比例。机构投资者持有该公司 19.77% 的股份，该公司专注于老年人的医疗保险优势计划</p>

<p>Clover Health Investments (NASDAQ:CLOV - Get Free Report) will likely be announcing its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $714.8940 million for the quarter. Investors may visit the the company's upcoming Q1 2026 earning results page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 5:00 PM ET.</p>
<div class="lb-trans"><p>Clover Health Investments（纳斯达克：CLOV - 获取免费报告）可能会在 2026 年 5 月 6 日星期三市场收盘后公布其 2026 年第一季度的业绩。分析师预计该公司将公布每股收益为 0.07 美元，季度收入为 7.14894 亿美元。投资者可以访问该公司即将发布的 2026 年第一季度财报页面，以获取关于定于 2026 年 5 月 6 日下午 5:00（东部时间）的电话会议的最新信息。</p>
</div><ul>
<li>MarketBeat Week in Review – 03/03 - 03/07</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 03/03 - 03/07</li>
</ul>
</div><p>Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its earnings results on Thursday, February 26th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by ($0.05). The firm had revenue of $487.71 million for the quarter, compared to analysts' expectations of $467.06 million. Clover Health Investments had a negative return on equity of 25.17% and a negative net margin of 4.45%. On average, analysts expect Clover Health Investments to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.</p>
<div class="lb-trans"><p>Clover Health Investments（纳斯达克：CLOV - 获取免费报告）上一次发布财报是在 2 月 26 日星期四。该公司报告季度每股收益为（0.10）美元，低于分析师一致预期的（0.05）美元，差距为（0.05）美元。该公司季度收入为 4.8771 亿美元，而分析师预期为 4.6706 亿美元。Clover Health Investments 的股本回报率为负 25.17%，净利润率为负 4.45%。分析师平均预计 Clover Health Investments 在当前财年和下一个财年将发布每股收益为 0 美元。</p>
</div><h2>Clover Health Investments Trading Up 4.8%</h2>
<div class="lb-trans"><h2>Clover Health Investments 股价上涨 4.8%</h2>
</div><p>Clover Health Investments stock opened at $2.64 on Wednesday. The firm has a 50-day moving average of $2.02 and a 200-day moving average of $2.40. The firm has a market cap of $1.39 billion, a P/E ratio of -15.53 and a beta of 2.24. Clover Health Investments has a 1-year low of $1.58 and a 1-year high of $3.92.</p>
<div class="lb-trans"><p>Clover Health Investments 的股票在星期三开盘价为 2.64 美元。该公司的 50 日移动平均线为 2.02 美元，200 日移动平均线为 2.40 美元。该公司的市值为 13.9 亿美元，市盈率为-15.53，贝塔值为 2.24。Clover Health Investments 的 1 年最低价为 1.58 美元，1 年最高价为 3.92 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>Missed the Hims &amp; Hers Rally? Clover Health Could Be Next</li>
</ul>
<div class="lb-trans"><ul>
<li>错过了 Hims &amp; Hers 的上涨？Clover Health 可能是下一个</li>
</ul>
</div><p>A number of analysts have recently weighed in on CLOV shares. Leerink Partners dropped their target price on shares of Clover Health Investments from $3.00 to $2.50 and set a &#34;market perform&#34; rating for the company in a report on Thursday, March 5th. Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of Clover Health Investments in a report on Friday, March 27th. Wall Street Zen upgraded shares of Clover Health Investments from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Sunday, February 15th. Finally, Canaccord Genuity Group dropped their target price on shares of Clover Health Investments from $3.70 to $3.20 and set a &#34;buy&#34; rating for the company in a report on Friday, March 20th. One research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of &#34;Hold&#34; and an average target price of $2.90.</p>
<div class="lb-trans"><p>一些分析师最近对 CLOV 股票发表了看法。Leerink Partners 在 3 月 5 日星期四的报告中将 Clover Health Investments 的目标价从 3.00 美元下调至 2.50 美元，并对该公司给予了 “市场表现” 评级。Weiss Ratings 在 3 月 27 日星期五的报告中重申了对 Clover Health Investments 的 “卖出（d-）” 评级。Wall Street Zen 在 2 月 15 日星期日的报告中将 Clover Health Investments 的评级从 “卖出” 上调至 “持有”。最后，Canaccord Genuity Group 在 3 月 20 日星期五的报告中将 Clover Health Investments 的目标价从 3.70 美元下调至 3.20 美元，并对该公司给予了 “买入” 评级。一位研究分析师对该股票给予了买入评级，三位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，平均目标价为 2.90 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on Clover Health Investments</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Clover Health Investments 的最新股票报告</strong></p>
</div><h2>Insider Buying and Selling at Clover Health Investments</h2>
<div class="lb-trans"><h2>Clover Health Investments 的内部买卖情况</h2>
</div><p>In other Clover Health Investments news, CEO Brady Patrick Priest sold 175,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $2.17, for a total transaction of $379,750.00. Following the completion of the transaction, the chief executive officer owned 1,998,584 shares of the company's stock, valued at approximately $4,336,927.28. This trade represents a 8.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Corporate insiders own 24.07% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Clover Health Investments 的新闻中，首席执行官 Brady Patrick Priest 在 3 月 4 日星期三出售了 175,000 股该公司的股票。股票以平均价格 2.17 美元出售，总交易额为 379,750.00 美元。交易完成后，首席执行官持有该公司 1,998,584 股股票，价值约为 4,336,927.28 美元。这笔交易代表了他们持股比例的 8.05% 的减少。该出售在向证券交易委员会提交的文件中披露，文件可通过此链接访问。公司内部人士持有该公司 24.07% 的股份。</p>
</div><h2>Hedge Funds Weigh In On Clover Health Investments</h2>
<div class="lb-trans"><h2>对 Clover Health Investments 的对冲基金观点</h2>
</div><p>Institutional investors and hedge funds have recently made changes to their positions in the business. Sei Investments Co. bought a new position in shares of Clover Health Investments during the second quarter valued at approximately $118,000. Russell Investments Group Ltd. bought a new position in shares of Clover Health Investments during the third quarter valued at approximately $104,000. Virtu Financial LLC bought a new position in shares of Clover Health Investments during the third quarter valued at approximately $101,000. Canada Pension Plan Investment Board bought a new position in shares of Clover Health Investments during the second quarter valued at approximately $88,000. Finally, Mackenzie Financial Corp bought a new position in shares of Clover Health Investments during the third quarter valued at approximately $80,000. Institutional investors own 19.77% of the company's stock.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近对该公司的持仓进行了调整。Sei Investments Co.在第二季度购买了 Clover Health Investments 的新头寸，价值约为 118,000 美元。Russell Investments Group Ltd.在第三季度购买了 Clover Health Investments 的新头寸，价值约为 104,000 美元。Virtu Financial LLC 在第三季度购买了 Clover Health Investments 的新头寸，价值约为 101,000 美元。加拿大养老金计划投资委员会在第二季度购买了 Clover Health Investments 的新头寸，价值约为 88,000 美元。最后，Mackenzie Financial Corp 在第三季度购买了 Clover Health Investments 的新头寸，价值约为 80,000 美元。机构投资者持有该公司 19.77% 的股份。</p>
</div><h2>About Clover Health Investments</h2>
<div class="lb-trans"><h2>关于 Clover Health Investments</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members.</p>
<div class="lb-trans"><p>Clover Health Investments 是一家以技术驱动的医疗保健公司，专注于为老年人群体提供医疗保险优势计划。该公司将保险覆盖与专有软件平台相结合，以改善护理协调、结果跟踪和成本管理。通过利用数据分析，Clover Health 旨在为其成员提供个性化的护理路径和预防干预措施。</p>
</div><p>At the core of Clover's offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams.</p>
<div class="lb-trans"><p>Clover 的核心产品是其 Clover Assistant 平台，该平台从多个来源聚合临床和索赔数据，为医生和护理团队提供实时洞察。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Clover Health Investments</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，而不是 Clover Health Investments</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=CLOV"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Clover Health Investments Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Clover Health Investments 吗？</h2>
</div><p>Before you consider Clover Health Investments, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Clover Health Investments 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每天推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 Clover Health Investments 并不在名单上。</p>
</div><p>While Clover Health Investments currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Clover Health Investments 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

三叶草健康投资公司（CLOV）预计将在周三公布季度财报